OMAN; SYRIAN ARAB REPUBLIC —Omani investment entity Al Batinah Development & Investment Holding SAOG (DBIH) has formally authorized negotiations to buy out Syria-based Al-Pharabi Veterinary Pharmaceuticals entire 35% stake in Al-Pharabi Company for Veterinary Medicines and Agricultural Company LLC. Located within Al-Buraimi Industrial City in Oman, the target enterprise is currently operating as a joint venture. Successful completion of the proposed transaction would consolidate Al Batinah's ownership stake from 65% to 100%, granting the holding firm full control over the animal health and agricultural production facility.
Al Batinah Development & Investment Holding SAOG (DBIH) is an Omani public joint stock company listed on the Muscat Stock Exchange, focused on strategic capital investments, corporate development, and portfolio management across regional industrial and commercial sectors. The target subsidiary specializes in the manufacturing and distribution of veterinary pharmaceuticals and agricultural health treatments to serve regional livestock and farm businesses.
The execution of the share transfer remains subject to regulatory conditions, including formal approvals and statutory registration procedures overseen by Oman's Ministry of Commerce, Industry, and Investment Promotion, along with relevant local administrative bodies. Upon securing full equity ownership, Al Batinah plans to restructure the legal framework and update the commercial brand identity of the subsidiary to align with its revised strategic corporate structure.
Consolidating total equity in localized industrial ventures highlights a growing strategic preference among Omani holding entities to secure direct operational control over regional pharmaceutical and agricultural supply chains. By eliminating cross-border joint venture complexities, the transition allows the parent firm to streamline governance, accelerate corporate decision-making, and capture full financial returns from Oman's expanding veterinary medicine sector.
